Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Harry Masuda | M | 79 |
Human BioSystems, Inc.
 Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
| George Tsukuda | M | - |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
| Larry McCleary | M | 73 |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | 4 años |
| Robert E. Strom | M | - |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
| Luis H. Toledo-Pereyra | M | 79 |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | 9 años |
| Rachmat M. Umar | M | - |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
| David Winter | M | 89 |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | 4 años |
| Frank J. Drechsler | M | 57 |
Human BioSystems, Inc.
Human BioSystems, Inc. Miscellaneous Commercial ServicesCommercial Services The Company's principal activity is to develop and provide economical, non-toxic methods of extending the shelf life and improving the quality of blood platelets and other biological material. The customers include blood banks, hospitals, clinics and similar organizations. The primary competitors include DuPont, Baxter, LifeCell, Cerus and Cryo Life. It is currently in the developmental stage. | - |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 8 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Paul Okimoto
- Red Personal
